[
  {
    "ts": null,
    "headline": "Amgen (AMGN) Suffers a Larger Drop Than the General Market: Key Insights",
    "summary": "Amgen (AMGN) closed at $259.30 in the latest trading session, marking a -1.28% move from the prior day.",
    "url": "https://finnhub.io/api/news?id=91617169e09e86e84d8201fe375ceacdc1c0d035ec0dfc5a09379882c261aad9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1735599619,
      "headline": "Amgen (AMGN) Suffers a Larger Drop Than the General Market: Key Insights",
      "id": 132208497,
      "image": "",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "Amgen (AMGN) closed at $259.30 in the latest trading session, marking a -1.28% move from the prior day.",
      "url": "https://finnhub.io/api/news?id=91617169e09e86e84d8201fe375ceacdc1c0d035ec0dfc5a09379882c261aad9"
    }
  },
  {
    "ts": null,
    "headline": "Is Amgen Inc. (AMGN) the Best Pharma Dividend Stock to Buy In 2024?",
    "summary": "We recently compiled a list of the 13 Best Pharma Dividend Stocks To Buy In 2024. In this article, we are going to take a look at where Amgen Inc. (NASDAQ:AMGN) stands against the other pharma dividend stocks. The pharmaceutical industry in 2024 faced a relatively quiet year, with deal volumes similar to 2023 but lower […]",
    "url": "https://finnhub.io/api/news?id=011c861318c049d7049fdbf638c840a4e4f1f47f98e00b8b5931ac5db710de59",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1735594573,
      "headline": "Is Amgen Inc. (AMGN) the Best Pharma Dividend Stock to Buy In 2024?",
      "id": 132206494,
      "image": "https://s.yimg.com/ny/api/res/1.2/Umivb7Omy8VqKH22zTmY9Q--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzM-/https://media.zenfs.com/en/insidermonkey.com/51e557354b24b248245adac46ac0da45",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "We recently compiled a list of the 13 Best Pharma Dividend Stocks To Buy In 2024. In this article, we are going to take a look at where Amgen Inc. (NASDAQ:AMGN) stands against the other pharma dividend stocks. The pharmaceutical industry in 2024 faced a relatively quiet year, with deal volumes similar to 2023 but lower […]",
      "url": "https://finnhub.io/api/news?id=011c861318c049d7049fdbf638c840a4e4f1f47f98e00b8b5931ac5db710de59"
    }
  },
  {
    "ts": null,
    "headline": "Chevron, Kimberly-Clark Among 15 Companies To Announce Dividend Increases In January",
    "summary": "Get the scoop on upcoming dividend increases from companies with long-term growth histories, including modest increases from Chevron and Kimberly-Clark in...",
    "url": "https://finnhub.io/api/news?id=bc456e33e15cf76dcaa8b97d53d4313285e1d1e774bdc8090f51d5d1802a753a",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1735585359,
      "headline": "Chevron, Kimberly-Clark Among 15 Companies To Announce Dividend Increases In January",
      "id": 132207437,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/459000811/image_459000811.jpg?io=getty-c-w1536",
      "related": "AMGN",
      "source": "SeekingAlpha",
      "summary": "Get the scoop on upcoming dividend increases from companies with long-term growth histories, including modest increases from Chevron and Kimberly-Clark in...",
      "url": "https://finnhub.io/api/news?id=bc456e33e15cf76dcaa8b97d53d4313285e1d1e774bdc8090f51d5d1802a753a"
    }
  }
]